Types of GLP-1 medications GLP-1 therapies are available in several different forms: Once-weekly injections Daily oral or injectable options Combination therapy with insulins Xultophy (insulin degludec + liraglutide) IcoSema (weekly insulin Icodec + Semaglutide) Soliqua (insulin glargine and lixisenatide) How the main GLP-1 drugs compare While all GLP-1 medications work through similar mechanisms, they differ in strength, dosing frequency, weight loss effects, and side-effect profiles
December 17, 2025: Federal Litigation Created for People Who Lost Their Vision After Taking Ozempic On December 15, 2025, the Joint Panel on Multidistrict Litigation (JPML) approved a request to consolidate lawsuits filed by people who experienced vision loss after taking Ozempic and other GLP-1 drugs
Studies on GLP-1 receptor agonists show modest increases in both amylase and lipase during treatment
The effectiveness of Ozempic is based on consistent weekly use, not the time of day
Acute bacterial exacerbations of chronic obstructive pulmonary disease due to Haemophilus influenzae, Moraxella catarrhalis or Streptococcus pneumoniae
